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Abstract
OBJECTIVES: To review the incidence, clinical presentation, deﬁnite management and 1-year outcome in patients with aorto-oesophageal
ﬁstulation (AOF) following thoracic endovascular aortic repair (TEVAR).
METHODS: International multicentre registry (European Registry of Endovascular Aortic Repair Complications) between 2001 and 2011
with a total caseload of 2387 TEVAR procedures (17 centres).
RESULTS: Thirty-six patients with a median age of 69 years (IQR 56–75), 25% females and 9 patients (19%) following previous aortic surgery
were identiﬁed. The incidence of AOF in the entire cohort after TEVAR in the study period was 1.5%. The primary underlying aortic path-
ology for TEVAR was atherosclerotic aneurysm formation in 53% of patients and the median time to development of AOF was 90 days (IQR
30–150). Leading clinical symptoms were fever of unknown origin in 29 (81%), haematemesis in 19 (53%) and shock in 8 (22%) patients.
Diagnosis could be conﬁrmed via computed tomography in 92% of the cases with the leading sign of a new mediastinal mass in 28 (78%)
patients. A conservative approach resulted in a 100% 1-year mortality, and 1-year survival for an oesophageal stenting-only approach was
17%. Survival after isolated oesophagectomy was 43%. The highest 1-year survival rate (46%) could be achieved via an aggressive treatment
including radical oesophagectomy and aortic replacement [relative risk increase 1.73 95% conﬁdence interval (CI) 1.03–2.92]. The survival
advantage of this aggressive treatment modality could be conﬁrmed in bootstrap analysis (95% CI 1.11–3.33).
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CONCLUSIONS: The development of AOF is a rare but lethal complication after TEVAR, being associated with the need for emergency
TEVAR as well as mediastinal haematoma formation. The only durable and successful approach to cure the disease is radical oesophagect-
omy and extensive aortic reconstruction. These ﬁndings may serve as a decision-making tool for physicians treating these complex
patients.
Keywords: Thoracic endovascular aortic repair • Aorto-oesophageal ﬁstulation • Complications • Treatment
INTRODUCTION
Thoracic endovascular aortic repair (TEVAR) has been rapidly
embraced by many physicians from different specialities as a
means to treat a broader cohort of patients with acute and chronic
thoracic aortic pathology [1–3]. Since the introduction of TEVAR in
the mid-90s, much has been learnt on the appropriate application
of the method as well as on pitfalls and their avoidance [4, 5].
However, there remains a black box regarding the occurrence of
orphan serious adverse events. In order to learn about these
mechanisms and their prevention in the future, the European
Registry of Endovascular Aortic Repair Complications (EuREC) was
founded. The ﬁrst two projects focused on the issue of retrograde
type A aortic dissection and the issue of symptomatic spinal cord
injury after TEVAR [6, 7].
The aim of the third EuREC project was to review the incidence,
clinical presentation, deﬁnite management and 1-year outcome in
patients with aorto-oesophageal ﬁstulation (AOF) following TEVAR.
METHODS
Patients
The records of 36 patients who developed AOF after TEVAR with a
median age of 69 years (IQR 56–75) between 2001 and 2011 were
analysed. The cumulative caseload of all 17 participating centres in
this time period was 2387. Twenty-ﬁve percent of patients were
female and 19% had already undergone various kinds of previous
open aortic surgery in different segments. The primary underlying
aortic pathology for TEVAR was thoracic aortic aneurysm in 53% of
patients, and the median time to the development of AOF was 90
days (IQR 30–150).
Deﬁnition of aorto-oesophageal ﬁstulation
AOF was deﬁned as any communication between the thoracic
aorta and the oesophagus post-TEVAR. Patients in whom AOF
could have been already present at the time of TEVAR or patients
having native AOF, either due to the underlying aortic pathology
or due to any reasons, were excluded.
Parameters
We collected clinical data, including any kind of previous aortic
surgery, underlying aortic pathology and extension of aortic
disease regarding the indication for TEVAR. Procedural data
included the time of TEVAR, elective or emergent intervention,
number of prostheses, covered length and landing zone according
to current deﬁnitions. Furthermore, the presence or absence of
mediastinal haematoma at the time of TEVAR was recorded. We
recorded the time between TEVAR and the diagnosis of AOF as
well as leading clinical symptoms. The diagnostic modalities of
AOF were recorded as was the strategy to treat AOF. Finally, 1-year
survival and reasons of death were recorded.
Statistical methods
Continuous data are presented as the median and IQR (range
from the 25th to 75th percentile). Discrete data are given as
counts and percentages. Comparisons of continuous data
between the patient cohorts were performed using the Mann–
Whitney U-test, and categorical data were compared using the
Fisher exact test. In the sub-analysis, we sought to determine the
optimal mode of treatment of oesophageal ﬁstulization following
TEVAR, and primary results are expressed as relative risk increase
(RRI) with its 95% conﬁdence interval (CI); the conservative treat-
ment option served as reference standard since 100% of patients
in this group died. A resampling model with 2000 replications was
then used to conﬁrm CIs. A two-sided P-value of <0.05 was con-
sidered statistically signiﬁcant. All calculations were performed
with SPSS 20.0 for Mac OsX (IBM SPSS, Inc., NY, USA).
RESULTS
Patient demographics
The incidence of AOF in the entire cohort after TEVAR in the study
period was 1.5%. The descriptive characteristics of the patient
cohort are depicted in Table 1. Coronary artery disease was
Table 1: Descriptive characteristics of the cohort
N overall = 36
Demographics
Age, median (IQR) 69 (56–75)
Female, n (%) 9 (25%)
Chronic health conditions and risk factors
Hypertension, n (%) 30 (83%)
Coronary artery disease, n (%) 8 (22%)
Previous cardiac surgery, n (%) 3 (8%)
Previous aortic surgery/intervention, n (%) 7 (19%)
Underlying pathology
Aneurysm, n (%) 19 (53%)
Acute type B aortic dissection, n (%) 5 (14%)
Penetrating atherosclerotic ulcers, n (%) 5 (14%)
Other, n (%) 7 (19%)
Underlying etiology
Atherosclerotic, n (%) 28 (78%)
Mycotic, n (%) 3 (8%)
Inflammatory, n (%) 2 (6%)
Other, n (%) 3 (8%)
Unless otherwise indicated, data are number (percentage). IQR:
interquartile range.
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present in 22% of patients, 19% had already undergone various
kinds of previous aortic surgeries and 8% had already undergone
previous cardiac surgery. The indications for TEVAR were athero-
sclerotic aneurysms in 53%, acute type B aortic dissections in 14%
and penetrating atherosclerotic ulcers in 14% (Table 1).
Index TEVAR procedure
Initial interventional characteristics of the cohort are given in
Table 2. Forty-four percent of patients underwent emergency
TEVAR and 36% had a detectable mediastinal haematoma at the
time of TEVAR. Severe intraoperative hypotension deﬁned as a
period of ≥ 5 min with a systolic pressure of <60mmHg was
observed in 3%. Details with regard to prior supra-aortic rerouting
procedures as well as the landing zones are given in Table 2. The
median covered length was 17 cm (IQR 15–22) and the median
oversizing factor of prostheses was 15% (IQR 0–30).
Presentation of aorto-oesophageal ﬁstulation
The median time interval between TEVAR and the diagnosis of
AOF was 90 days (IQR 30–150). Clinical symptoms were fever of
unknown origin in 81%, haematemesis in various extents in 53%
and shock in 22% (septic and/or haemorrhagic) (Table 3). Imaging
was preferably done by computed tomography (CT)—92% fol-
lowed by conﬁrmation of the suspected diagnosis by endoscopy
in 50% (Figs 1 and 2). Median serum CRP levels at the time of diag-
nosis were 18 mg/dl (IQR 10–27).
Management of aorto-oesophageal ﬁstulation
In 28%, a conservative strategy was chosen, and an oesophageal
stenting-only approach in 17%. Nineteen percent underwent iso-
lated oesophagectomy and ﬁnally, 36% of patients underwent a
radical surgical approach of both oesophagectomy and aortic
replacement of various kinds (Table 4). In these patients, stent-
grafts were removed in toto. Figure 3 shows the intraoperative situs
of a patient undergoing such a radical surgical approach. Figure 4A
shows the situs post-oesophagectomy and after orthotopic recon-
struction of the thoracic segment with a bovine pericardial
neoaorta.
Follow-up
Two patients who initially underwent an oesophagectomy-only
approach, subsequently underwent extension TEVAR procedures
proximally and distally to the initially repaired segment due to
continuing mycotic aneurismal formation. One patient underwent
revision of the gastric pull-up anastomosis due to dehiscence.
One-year survival was 28% (n = 10). Thirteen patients died due
to bleeding complications as a consequence of the continuing in-
fective process. Fatal bleeding complications occurred via arrosion
of the adjacent anatomical structures. Mediastinitis and multior-
gan failure accounted for 4 deaths each and have also to be seen
in context with the active infective process. One patient died due
to respiratory failure after surgery and another 4 deaths were clas-
siﬁed as sudden cardiac and therefore not related to AOF.
A conservative approach resulted in a 100% 1-year mortality,
and 1-year survival for an oesophageal- stenting-only approach
was 17%. Survival after isolated oesophagectomy was 43%. The
highest 1-year survival rate (46%) could be achieved via an aggres-
sive treatment including radical oesophagectomy and aortic re-
placement [RRI 1.73 95% CI 1.03–2.92]. The survival advantage of
this aggressive treatment modality could be conﬁrmed in boot-
strap analysis (95% CI 1.11–3.33). Figure 4B shows the ﬁnal result in
patients after orthotopic aortic reconstruction and gastric pull-up.
COMMENT
The development of AOF is a rare but lethal complication after
TEVAR, being associated with the need for emergency TEVAR as
well as mediastinal haematoma formation. The only durable and
successful approach to cure the disease is radical oesophagectomy
and extensive aortic reconstruction. These ﬁndings may serve as a
Table 2: Initial interventional characteristics of the cohort
N overall = 36
Initial procedure
Emergency, (%) 16 (44%)
Prior supra-aortic rerouting, n (%) 3 (8%)
Overstenting of arch vessels, n (%) 5 (14%)
Proximal bare metal springs, n (%) 14 (39%)
Criado zone 0, n (%) 1 (3%)
Criado zone 1, n (%) 6 (17%)
Criado zone 2, n (%) 8 (22%)
Criado zone 3, n (%) 19 (53%)
Stent coverage
Number of protheses, median (range) 1 (1–4)
Coverage in cm, median (IQR) 17 (15–22)
Oversizing factor in percentages, median (range) 15 (0–30)
Previous aortic surgery/ intervention, n (%) 7 (19%)
Mediastinal haematoma at diagnosis, n (%) 13 (36%)
Intraoperative hypotension, n (%) 1 (3%)
Unless otherwise indicated, data are number (percentage).
IQR: interquartile range.
Table 3: Presentation of aorto-oesophageal fistulation
N overall = 36
Timing
Days since initial TEVAR procedure, median (IQR) 90 (30–150)
Clinical presentation
Fever of unknown origin, n (%) 29 (81%)
Haematemesis, n (%) 19 (53%)
Shock, n (%) 8 (22%)
Dyspnoea, n (%) 2 (6%)
Others, n (%) 3 (8%)
Diagnostics
Computed tomography, n (%) 33 (92%)
Partial thrombosis, n (%) 7 (19%)
Confirmation via endoscopy, n (%) 18 (50%)
Acute phase protein, mg/dl, median (IQR) 18 (10–27)
Unless otherwise indicated, data are number (percentage).
IQR: interquartile range.
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decision-making tool for physicians treating these complex
patients.
It was interesting to realize that a substantial number of patients
had undergone emergency TEVAR and according to the active
underlying aortic disease progress had mediastinal haematoma for-
mation at the time of TEVAR. We feel that this is potentially the
most important ﬁnding of our study. Years ago, when we had our
ﬁrst case of AOF, which was a ‘simple’ monosegmental rupture of
the descending aorta, we hypothesized that elevated pressure in
the posterior mediastinum could well be responsible for secondary
oesophageal ischaemia and consequently AOF formation also due
to the inﬂammation of the resorption haematoma [8]. This mechan-
ism has also been postulated by others and may therefore now be
seen as one proven way to develop AOF [9, 10]. In our setting, we
try to attenuate this problem by elective left-sided mini-
thoracotomy on the second day after TEVAR with broad opening of
the mediastinal pleura in order to decompress the posterior medi-
astinum. It is clear that this approach might not be applicable to all
patients, but it might serve as a technical tip to avoid this dreadful
complication. Another radiographic ﬁnding which should increase
alertness constitutes right-sided haemothorax as a surrogate for ex-
cessive pressure formation in the posterior mediastinum leading to
secondary right-sided pleural rupture.
Furthermore, the size of the aneurysm may play another
leading role in the development of AOF. It is known that AOF and
also aortobronchial ﬁstulization may occur as a natural course of
huge thoracic aneurysms without any intervention [11]. The mech-
anism here may be seen in mechanical compression and second-
ary erosion. The geometry change in the aortic arch and the
descending aorta by TEVAR as well as the radial force of the graft
against the native aortic wall may lead to the same ﬁnal pathway
of ischaemia and secondary ﬁstula formation.
Obviously, AOF formation is a gradual process as the median
time to developing AOF in our study was 90 days. Interestingly, we
did not observe a single case of primary fatal free rupture of AOF,
indicating that the natural course of the disease is stepwise.
However, clinical and laboratory sings of inﬂammation are very
common [9, 10]. Eighty-one percent of our patients had fever
as the leading clinical sign in combination with haematemesis to
various extents in 50% of patients. This combination should alert
the treating physician to the problem and enhance the establish-
ment of an appropriate diagnosis and an adequate treatment strat-
egy.
Diagnosis was—as expected—mainly established by CT imaging.
A new mediastinal mass was present in 19% of patients, suggesting
contained rupture. However, the leading radiographic sign
remains air surrounding the prosthesis and the posterior mediasti-
num. Diagnosis was conﬁrmed by additional endoscopy in 50% of
patients and it has been used as primary diagnostic means in
casuistics with the leading clinical sign of haematemesis.
Figure 1: CT of a 58-year old female with AOF after TEVAR for acute complicated type B aortic dissection. (A), volume rendered image displaying the thoracic aorta
and the close spatial relation of the stent graft and the oesophagus (blue). Dotted blue lines indicate the position of the transverse views in (B–D): (B) at the level below
the tracheal bifurcation with the oesophagus (arrow) located posteriorly to the left main bronchus and medial to the aorta; (C) at the level of the left atrium with the
oesophagus (arrows) intersecting anteriorly to the aorta with slit-shaped compression between aorta and left atrium. (D) Further below, the oesophagus is located left
to the aorta (arrow) with air adjacent to the stent graft (open arrow), corresponding to the AOF.
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Due to the associated high degree of systemic inﬂammation in
patients with AOF and the fact that they underwent primary TEVAR
instead of open surgery, these patients were selected for a higher
degree of frailty and consecutively for a lower probability of being
suitable for open repair [4]. This is reﬂected by the fact that in this
study, a conservative approach had to be chosen in 28% of
patients. By analysing the different treatment strategies, it became
obvious that any trade-off regarding debridement of infected
structures, irrespective if oesophagus or stent-graft is prone to
failure. The highest success rates were achieved in patients for
whom a radical strategy with oesophagectomy and removal of the
stent-graft with orthotopic aortic reconstruction was chosen. It
seems wise to delay oesophageal reconstruction due to the higher
probability of primary anastomotic healing of a gastric pull-up or a
colonic interposition [8]. From our database, we cannot draw
conclusions regarding whether the entire aortic wall was removed
during surgery. However, as there was no recurrence of infection
in the radically treated group, it is highly likely that all patients
Table 4: The management and outcome of aorto-
oesophageal fistulation
N overall = 36
Management
Conservative, n (%) 10 (28%)
Oesophageal stenting only, n (%) 6 (17%)
Isolated oesophagectomy, n (%) 7 (19%)
Aortic replacement plus oesophagectomy, n (%) 13 (36%)
Outcome
1-year survival, n (%) 10 (28%)
Unless otherwise indicated, data are number (percentage).
Figure 3: Intraoperative view of a patient with AOF showing the aneurismal sac
open, as well as the spatial relation of the stent-graft to the defect in the oe-
sophageal wall.
Figure 4: (A). Intraoperative view after oesophagectomy and orthotopic recon-
struction with a bovine pericardial neoaorta. (B). CT 3 months after orthotopic
aortic reconstruction and gastric pull-up.
Figure 2: Endoscopic view of AOF showing the stents and fabric of the stent-
graft protruding into the oesophageal lumen.
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were treated properly without knowing the details regarding
whether all remnants of the aortic wall were removed. In case of
remaining dead space, the use of Dacron grafts or in case of direct
oesophageal suture, omentopexy is highly useful to enhance the
healing process in a fragile area [12].
Regarding the material of choice for aortic replacement, several
options are available where the implantation of a Dacron graft
with or without antibiotic treatment might be at higher risk for
infection. However, several other groups have reported very fa-
vourable results using Dacron grafts with antibiotic treatment
[12, 13]. We have developed a new means of orthotopic aortic re-
construction by using a bovine pericardial patch as a neoaorta
with excellent success rates with regard to freedom from reinfec-
tion [14]. Additionally, calciﬁcation of this graft after a median
follow-up of 24 months is not an issue, which might prove this ap-
proach to be superior to homograft replacement in the long-term.
Regarding the reasons for death, bleeding complications had
a leading role due to the continuing infective process. Fatal
bleeding complications occurred via arrosion of the adjacent ana-
tomical structures. Despite 1-year survival in patients with an
oesophagectomy-only approach being only slightly less than in
patients with a radical approach to both aorta and esophagus, a
risk of reinfection remains as shown by 2 cases who had already
undergone extension TEVAR procedures proximally and distally to
the initially repaired segment due to continuing mycotic aneur-
ismal formation. Furthermore, these patients have to remain
under life-long antibiotic therapy, which is usually not the case in
patients undergoing a radical approach.
Strengths and limitations of this study
This study represents a systematic approach to learning about the
incidence, mechanisms and treatment strategies of AOF after
TEVAR. However, it is clear that not every patient undergoing
emergency TEVAR having mediastinal haematoma will develop
AOF. As such, this report is not the answer to all questions.
Summarizing, the development of AOF is a rare but lethal
complication after TEVAR, being associated with the need for
emergency TEVAR as well as mediastinal haematoma formation.
The only durable and successful approach to cure the disease is
radical oesophagectomy and extensive aortic reconstruction.
These ﬁndings may serve as a decision-making tool for physicians
treating these complex patients.
Conﬂict of interest: none declared.
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